Adenoviral gene transfer of sphingosine kinase 1 protects heart against ischemia/reperfusion-induced injury and attenuates its postischemic failure.

Abstract:

:Sphingosine kinase 1 (SPK1) has been identified as a central mediator of ischemia preconditioning and plays a protective role in ischemia/reperfusion (I/R)-induced cardiomyocyte death. In the present study, we investigated the protective effect of adenovirus-mediated SPK1 gene (Ad-SPK1) transfer on I/R-induced cardiac injury, and evaluated its therapeutic action on postinfarction heart failure. Cardiac SPK1 activity was increased about 5-fold by injection of Ad-SPK1, compared with injection of adenovirus carrying the green fluorescent protein gene (Ad-GFP). A more potent performance and a lower incidence of arrhythmia were observed in Ad-SPK1-injected hearts during the reperfusion period, compared with Ad-GFP-injected hearts. An enzymatic activity assay showed that creatine kinase release was also less in Ad-SPK1-injected hearts. To investigate the therapeutic action of the SPK1 gene on postischemic heart failure, the left anterior descending branch of the coronary artery in Wistar rats was ligated after direct intramyocardial injection of Ad-SPK1 or Ad-GFP as a control. Ad-SPK1 injection significantly preserved cardiac systolic and diastolic function, as evidenced by left ventricular (LV) systolic pressure, LV end-diastolic pressure, and peak velocity of contraction (dP/dt). The LV morphometric parameters of Ad-SPK1-treated animals were also preserved. In addition, SPK1 gene delivery significantly enhanced angiogenesis and reduced fibrosis. These results demonstrate that adenovirus-mediated SPK1 gene transfer could efficiently prevent I/R-induced myocardial injury and attenuate postischemic heart failure. Thus, SPK1 gene delivery would be a novel strategy for the treatment of coronary heart disease.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Duan HF,Wang H,Yi J,Liu HJ,Zhang QW,Li LB,Zhang T,Lu Y,Wu CT,Wang LS

doi

10.1089/hum.2007.036

subject

Has Abstract

pub_date

2007-11-01 00:00:00

pages

1119-28

issue

11

eissn

1043-0342

issn

1557-7422

journal_volume

18

pub_type

杂志文章
  • Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cells.

    abstract::Production of clinical-grade gammaretroviral vectors for ex vivo gene delivery requires a scalable process that can rapidly generate large amounts of vector supernatant, clear large numbers of residual packaging cells with minimal decreases in vector titer, and satisfy all current regulatory guidelines regarding produ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2010.064

    authors: Feldman SA,Goff SL,Xu H,Black MA,Kochenderfer JN,Johnson LA,Yang JC,Wang Q,Parkhurst MR,Cross S,Morgan RA,Cornetta K,Rosenberg SA

    更新日期:2011-01-01 00:00:00

  • Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat.

    abstract::Current clinical gene therapy protocols for the treatment of human immunodeficiency virus type 1 (HIV-1) infection often involve the ex vivo transduction and expansion of CD4+ T cells derived from HIV-positive patients at a late stage in their disease (CD4 count <400). These protocols involve the transduction of T cel...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.4-487

    authors: Poznansky MC,Foxall R,Mhashilkar A,Coker R,Jones S,Ramstedt U,Marasco W

    更新日期:1998-03-01 00:00:00

  • Gene Editing for Treatment and Prevention of Human Diseases: A Global Survey of Gene Editing-Related Researchers.

    abstract::In the next decades, gene editing technologies are expected to be used in the treatment and prevention of human diseases. Yet, the future uses of gene editing in medicine are still unknown, including its applicability and effectiveness to the treatment and prevention of infectious diseases, cancer, and monogenic and p...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2020.136

    authors: Rocha LFM,Braga LAM,Mota FB

    更新日期:2020-08-01 00:00:00

  • Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I.

    abstract::Leukocyte adhesion deficiency type I (LAD-I) is a primary immunodeficiency caused by mutations in the ITGB2 gene and is characterized by recurrent and life-threatening bacterial infections. These mutations lead to defective or absent expression of β2 integrins on the leukocyte surface, compromising adhesion and extrav...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2016.016

    authors: Leon-Rico D,Aldea M,Sanchez-Baltasar R,Mesa-Nuñez C,Record J,Burns SO,Santilli G,Thrasher AJ,Bueren JA,Almarza E

    更新日期:2016-09-01 00:00:00

  • Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma.

    abstract::The purpose of this study was to determine the safety and antitumor activity of IFN-gamma retroviral vector in patients with advanced melanoma. Seventeen patients (9 single courses, 8 multiple courses) received a total of 363 intratumor injections of IFN-gamma retroviral vector (1 x 10(7) PFU/ml administered at 0.3, 0...

    journal_title:Human gene therapy

    pub_type: 临床试验,杂志文章

    doi:10.1089/10430349950017978

    authors: Nemunaitis J,Fong T,Burrows F,Bruce J,Peters G,Ognoskie N,Meyer W,Wynne D,Kerr R,Pippen J,Oldham F,Ando D

    更新日期:1999-05-20 00:00:00

  • Heat-directed tumor cell fusion.

    abstract::In previous studies we demonstrated that a modified human HSP70b promoter (HSE.70b) directs high levels of gene expression to tumor cells after mild hyperthermia treatment in the range of 41.5-44 degrees C. This transcriptional targeting system exhibits low basal activity at 37 degrees C, is highly induced (950-fold) ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303403321467216

    authors: Brade AM,Szmitko P,Ngo D,Liu FF,Klamut HJ

    更新日期:2003-03-20 00:00:00

  • Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.

    abstract::Laminin-5 is composed of three distinct polypeptides, alpha3, beta3, and gamma2, which are encoded by three different genes, LAMA3, LAMB3, and LAMC2, respectively. We have isolated epidermal keratinocytes from a patient presenting with a lethal form of junctional epidermolysis bullosa characterized by a homozygous mut...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.9-1359

    authors: Dellambra E,Vailly J,Pellegrini G,Bondanza S,Golisano O,Macchia C,Zambruno G,Meneguzzi G,De Luca M

    更新日期:1998-06-10 00:00:00

  • Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival.

    abstract::Adrenomedullin (AM) has been shown to protect against ischemia/reperfusion-induced myocardial infarction and apoptosis. In the present study, we examined the potential neuroprotective action of delayed AM gene transfer in cerebral ischemia. Three days after a 1-hr occlusion of the middle cerebral artery (MCAO), rats w...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2004.15.1243

    authors: Xia CF,Yin H,Borlongan CV,Chao J,Chao L

    更新日期:2004-12-01 00:00:00

  • Engineered U7 Small Nuclear RNA Restores Correct β-Globin Pre-mRNA Splicing in Mouse βIVS2-654-Thalassemic Erythroid Progenitor Cells.

    abstract::Restoration of correct splicing of βIVS2-654-globin pre-mRNA was previously accomplished in erythroid cells from β-thalassemia/HbE patients by an engineered U7 small nuclear RNA (snRNA) that carried a sequence targeted to the cryptic branch point and an exonic splicing enhancer, U7.BP+623 snRNA. In this study, this ap...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2020.145

    authors: d'Arqom A,Nualkaew T,Jearawiriyapaisarn N,Kole R,Svasti S

    更新日期:2020-11-02 00:00:00

  • A microinjected COL7A1-PAC vector restores synthesis of intact procollagen VII in a dystrophic epidermolysis bullosa keratinocyte cell line.

    abstract::Dystrophic epidermolysis bullosa (DEB) comprises a family of inherited blistering skin disorders for which no corrective therapy currently exists. In the most severe form, the Hallopeau-Siemens subtype (RDEB-HS), the epidermal adhesion protein collagen VII is absent from the skin as a consequence of null mutations in ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340260201743

    authors: Mecklenbeck S,Compton SH,Mejía JE,Cervini R,Hovnanian A,Bruckner-Tuderman L,Barrandon Y

    更新日期:2002-09-01 00:00:00

  • Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients.

    abstract::Immunologically sensitized recipients present one of the most critical problems in clinical organ transplantation today, since preformed antibodies rapidly destroy donor tissue expressing specific MHC class I antigens (Ag). Therefore, sensitized patients are either unable to receive a compatible organ, or experience a...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050015923

    authors: Geissler EK,Graeb C,Tange S,Guba M,Jauch KW,Scherer MN

    更新日期:2000-02-10 00:00:00

  • Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.

    abstract::The central nervous system (CNS) is a predominant site of involvement in several lysosomal storage diseases (LSDs); and for many patients, these diseases are diagnosed only after the onset of symptoms related to the progressive accumulation of macromolecules within lysosomes. The mucopolysaccharidosis type VII (MPS VI...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050015707

    authors: Sferra TJ,Qu G,McNeely D,Rennard R,Clark KR,Lo WD,Johnson PR

    更新日期:2000-03-01 00:00:00

  • Polyploidization without mitosis improves in vivo liver transduction with lentiviral vectors.

    abstract::Lentiviral vectors are efficient gene delivery vehicles for therapeutic and research applications. In contrast to oncoretroviral vectors, they are able to infect most nonproliferating cells. In the liver, induction of cell proliferation dramatically improved hepatocyte transduction using all types of retroviral vector...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2011.227

    authors: Pichard V,Couton D,Desdouets C,Ferry N

    更新日期:2013-02-01 00:00:00

  • Capsid Engineering of Adenovirus Vectors: Overcoming Early Vector-Host Interactions for Therapy.

    abstract::Adenovirus-based vectors comprise the most frequently used vector type in clinical studies to date. Both intense lab research and insights from the clinical trials reveal the importance of a comprehensive understanding of vector-host interactions. Especially for systemic intravenous adenovirus vector delivery, it is p...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2017.139

    authors: Hagedorn C,Kreppel F

    更新日期:2017-10-01 00:00:00

  • Rescue of Adeno-Associated Virus Production by shRNA Cotransfection.

    abstract::Adeno-associated virus (AAV) vector technology is rapidly advancing and becoming not only the leading vector platform in the field of gene therapy but also a useful tool for functional genomic studies of novel proteins. As most vectors utilize constitutive promoters, this results in transgene expression during product...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2019.249

    authors: Guimaro MC,Afione SA,Tanaka T,Chiorini JA

    更新日期:2020-10-01 00:00:00

  • Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.

    abstract::Vectors derived from the human parvovirus AAV-2 (adeno-associated virus type 2) are among the most promising gene delivery vehicles currently being developed. These vectors are not only capable of transducing a large variety of human cell types in vitro and in vivo, but in immunocompetent animal models can establish l...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/10430349950016799

    authors: Grimm D,Kleinschmidt JA

    更新日期:1999-10-10 00:00:00

  • Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy.

    abstract::Establishing pharmacological parameters, such as efficacy, routes of administration, and toxicity, for recombinant adeno-associated virus (rAAV) vectors is a prerequisite for gaining acceptance for clinical applications. In fact, even a therapeutic window, that is, the dose range between therapeutic efficacy and toxic...

    journal_title:Human gene therapy

    pub_type: 杂志文章,评审

    doi:10.1089/hum.2009.092

    authors: Virag T,Cecchini S,Kotin RM

    更新日期:2009-08-01 00:00:00

  • Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.

    abstract::Interleukin-12 (IL-12) is a heterodimeric cytokine that plays an important role in the development of cellular immunity. Clinical applications for this lymphokine include resolution of infectious disease, cancer immunotherapy, and boosting cellular immunity in AIDS patients. When using IL-12 and other cytokines therap...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.3-333

    authors: Bramson J,Hitt M,Gallichan WS,Rosenthal KL,Gauldie J,Graham FL

    更新日期:1996-02-10 00:00:00

  • Adenovirus-mediated transfer of an Na+/K+-ATPase beta1 subunit gene improves alveolar fluid clearance and survival in hyperoxic rats.

    abstract::Pulmonary edema is cleared via active Na(+) transport by alveolar epithelial Na(+)/K(+)-ATPases and Na(+) channels. Rats exposed to acute hyperoxia have a high mortality rate, decreased Na(+)/K(+)-ATPase function, and decreased alveolar fluid clearance (AFC). We hypothesized that Na(+)/K(+)-ATPase subunit gene overexp...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303400750035753

    authors: Factor P,Dumasius V,Saldias F,Brown LA,Sznajder JI

    更新日期:2000-11-01 00:00:00

  • Antiapoptotic small interfering RNA as potent adjuvant of DNA vaccination in a mouse mammary tumor model.

    abstract::In vivo electroporation of plasmid DNA (DNA-EP) is an efficient and safe method for vaccines. It results in increased DNA uptake, enhances protein expression, and augments immune responses to the target antigen in a variety of species. To further improve the efficacy of DNA-EP, we evaluated small interfering RNA (siRN...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2008.210

    authors: Dharmapuri S,Aurisicchio L,Biondo A,Welsh N,Ciliberto G,La Monica N

    更新日期:2009-06-01 00:00:00

  • Characterization of lentiviral vector-mediated gene transfer in adult mouse brain.

    abstract::Lentiviral vectors are promising tools for gene transfer into the central nervous system. We have characterized in detail transduction with human immunodeficiency virus type 1 (HIV-1)-derived vectors encoding enhanced green fluorescent protein (eGFP) in the adult mouse brain. Different brain regions such as the striat...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340252899019

    authors: Baekelandt V,Claeys A,Eggermont K,Lauwers E,De Strooper B,Nuttin B,Debyser Z

    更新日期:2002-05-01 00:00:00

  • Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells.

    abstract::Clinical trials of gene therapy using a viral delivery system for glioma have been limited. Recently, gene therapy using stem cells as the vehicles for delivery of therapeutic agents has emerged as a new treatment strategy for malignant brain tumors. In this study, we used human umbilical cord blood-derived mesenchyma...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2010.187

    authors: Ryu CH,Park SH,Park SA,Kim SM,Lim JY,Jeong CH,Yoon WS,Oh WI,Sung YC,Jeun SS

    更新日期:2011-06-01 00:00:00

  • Lentiviral-mediated RNA interference.

    abstract::RNA interference (RNAi) is a form of posttranscriptional gene silencing mediated by short double-stranded RNA, known as small interfering RNA (siRNA). These siRNAs are capable of binding to a specific mRNA sequence and causing its degradation. The recent demonstration of a plasmid vector that directs siRNA synthesis i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303402320987888

    authors: Abbas-Terki T,Blanco-Bose W,Déglon N,Pralong W,Aebischer P

    更新日期:2002-12-10 00:00:00

  • Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice.

    abstract::We previously demonstrated that intramuscular plasmid injection serves as a useful method of long-term systemic delivery of cytokines. In the present study, we assess intramuscular DNA injection as a means of systemically delivering interleukin 10 (IL-10), a cytokine with immunosuppressive properties, and preventing t...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.12-1701

    authors: Nitta Y,Tashiro F,Tokui M,Shimada A,Takei I,Tabayashi K,Miyazaki J

    更新日期:1998-08-10 00:00:00

  • Maternal Therapy with Ad.VEGF-A165 Increases Fetal Weight at Term in a Guinea-Pig Model of Fetal Growth Restriction.

    abstract::In a model of growth-restricted sheep pregnancy, it was previously demonstrated that transient uterine artery VEGF overexpression can improve fetal growth. This approach was tested in guinea-pig pregnancies, where placental physiology is more similar to humans. Fetal growth restriction (FGR) was attained through peri-...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2016.046

    authors: Swanson AM,Rossi CA,Ofir K,Mehta V,Boyd M,Barker H,Ledwozyw A,Vaughan O,Martin J,Zachary I,Sebire N,Peebles DM,David AL

    更新日期:2016-12-01 00:00:00

  • Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney.

    abstract::Recombinant adenoviruses have great potential as gene delivery systems because of their ability to infect a wide range of target cells. However, systemic delivery of viral vectors to tissues other than liver and spleen has been inefficient because of the rapid clearance of the circulating virus by the liver. In the pr...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050015806

    authors: Ye X,Jerebtsova M,Ray PE

    更新日期:2000-03-01 00:00:00

  • Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy.

    abstract::Approaches to alter the native tropism of adenoviruses (Ads) are beneficial to increase their efficacy and safety profile. Liver tropism is important with regard to potential clinical toxicity in humans. Ad5/3 chimeras in which the Ad5 knob is substituted by the Ad3 knob, such as Ad5/3luc1, have been recently shown to...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340460745829

    authors: Breidenbach M,Rein DT,Wang M,Nettelbeck DM,Hemminki A,Ulasov I,Rivera AR,Everts M,Alvarez RD,Douglas JT,Curiel DT

    更新日期:2004-05-01 00:00:00

  • Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury.

    abstract::Hyperoxia and ischemia-reperfusion cause profound lung cellular damage mediated, in part, by generation of oxygen radicals. We hypothesized that gene therapy can be used to overcome oxidant injury by augmenting intracellular antioxidant enzymes. Adult rats were injected intratracheally with an adenovirus (Ad) vector e...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.10-1487

    authors: Danel C,Erzurum SC,Prayssac P,Eissa NT,Crystal RG,Hervé P,Baudet B,Mazmanian M,Lemarchand P

    更新日期:1998-07-01 00:00:00

  • Association of NPC1L1 and HMGCR Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease.

    abstract::Three-vessel disease (TVD) is a severe coronary heart disease (CHD) with poor prognosis. Niemann-Pick C1-like 1 (NPC1L1) is a transporter protein for exogenous cholesterol absorption, and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) is a rate-limiting enzyme for cholesterol synthesis. We aimed to investigat...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2020.229

    authors: Zhao X,Li J,Tang X,Liu R,Xu J,Xu L,Jiang L,Huang K,Tian J,Feng X,Wu Y,Zhang Y,Wang D,Sun K,Xu B,Zhao W,Hui R,Gao R,Song L,Yuan J

    更新日期:2021-01-22 00:00:00

  • Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage.

    abstract::Successful gene transfer into articular cartilage is a prerequisite for gene therapy of articular joint disorders. In the present study we tested the hypothesis that recombinant adeno-associated virus (rAAV) vectors are capable of effecting gene transfer in isolated articular chondrocytes in vitro, articular cartilage...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303403321208998

    authors: Madry H,Cucchiarini M,Terwilliger EF,Trippel SB

    更新日期:2003-03-01 00:00:00